Tanke Biosciences Valuation
| TNBI Stock | USD 0.02 0.01 33.33% |
Tanke Biosciences seems to be undervalued based on Macroaxis valuation methodology. Our model measures the value of Tanke Biosciences from inspecting the company fundamentals such as Return On Equity of -0.1, shares outstanding of 13.32 M, and insignificant Operating Margin as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Tanke Biosciences' price fluctuation is out of control at this time. Calculation of the real value of Tanke Biosciences is based on 3 months time horizon. Increasing Tanke Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tanke Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tanke Pink Sheet. However, Tanke Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.02 | Real 0.0244 | Hype 0.02 |
The intrinsic value of Tanke Biosciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Tanke Biosciences' stock price.
Estimating the potential upside or downside of Tanke Biosciences helps investors to forecast how Tanke pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tanke Biosciences more accurately as focusing exclusively on Tanke Biosciences' fundamentals will not take into account other important factors: Tanke Biosciences Total Value Analysis
Tanke Biosciences is at this time forecasted to have valuation of 4.56 M with market capitalization of 2 M, debt of 0, and cash on hands of 5.09 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tanke Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.56 M | 2 M | 0 | 5.09 M |
Tanke Biosciences Investor Information
The company has price-to-book ratio of 0.02. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tanke Biosciences recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. The firm had 125:1064 split on the 10th of February 2011. Based on the key indicators related to Tanke Biosciences' liquidity, profitability, solvency, and operating efficiency, Tanke Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Tanke Biosciences Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Tanke signifies not a very effective usage of assets in December.Tanke Biosciences Profitability Analysis
The company reported the previous year's revenue of 28.56 M. Net Loss for the year was (210.25 K) with profit before overhead, payroll, taxes, and interest of 9.94 M.About Tanke Biosciences Valuation
An absolute valuation paradigm, as applied to Tanke Pink Sheet, attempts to find the value of Tanke Biosciences based on its fundamental and basic technical indicators. By analyzing Tanke Biosciences's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Tanke Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tanke Biosciences. We calculate exposure to Tanke Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tanke Biosciences's related companies.Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.
8 Steps to conduct Tanke Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Tanke Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tanke Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tanke Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tanke Biosciences' revenue streams: Identify Tanke Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tanke Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tanke Biosciences' growth potential: Evaluate Tanke Biosciences' management, business model, and growth potential.
- Determine Tanke Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tanke Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Tanke Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | 2.9 M |
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |